smart talk

SMART TALK: The state of the cell and gene therapy industry

June 11, 2019

The cell and gene therapy industry is growing rapidly, and as a result, faces new challenges. Realizing the potential of innovative cell and gene therapy treatments relies upon the industry's ability to meet these challenges.


HemaCare recognizes two major needs of advancing treatments: quality starting materials and refined manufacturing processes. This discussion will explore:

  • how the quality of starting materials impacts all stages of production—from R&D through commercialization.
  • why consistent process control is essential to accomplishing quality, simplified, large-scale manufacturing on a global scale.
  • How HemaCare plans to address these needs and contribute to the future successes of cell and gene therapies.



Dr. Dominic Clarke

Global Head of Cell Therapy, HemaCare

12-1:30 p.m.


2nd floor

3675 Market Street

Philadelphia, PA